The honest truth about month 2
Month 2 is the period of maximum patient anxiety — and the period when the least has visibly changed. The shock loss is complete or nearly complete. Greffeed hair has shed. Nouveau growth has not yet started. The scalp may look sparser than avant de the procedure. Patients often contact their clinic convinced the transplant has failed.
This appearance is entirely normal. It is not failure. The follicles are alive beneath the surface — in telogen, the resting phase — recovering from surgical trauma avant de re-entering anagen. Month 2 is winter. Spring comes at months 3–5.
The biology of month 2 — what is actually happening
After surgery, transplanted follicles enter telogen due to the physical and chemical stress of extraction, handling and implantation. The telogen phase typically lasts 8–16 weeks — placing month 2 squarely in the middle of this dormant window. The follicle is intact, alive and cycling. The hair shaft has shed; a new shaft is being prepared for the anagen entry that will occur at months 3–5.
An accurate analogy: a bulb planted in autumn shows no growth in early winter — but the bulb is alive and will emerge in spring. The absence of visible growth at month 2 is biologically identical to this situation.
Normal at month 2 vs when to contact the clinic
Normal and expected: No new growth visible. Sparse appearance. Mild residual redness. Some itching as follicles recover.
Contact Hairmedico if: Signs of infection (increasing redness, heat, discharge, fever). Significant folliculitis that does not respond to warm compress. Unusual or increasing pain after the first week.
At Hairmedico, all patients have direct WhatsApp access to the medical team throughout the 12-month follow-up. Any photograph can be submitted for assessment within hours.
Frequently Asked Questions
Yes. AI is used for trichoscopy donor density mapping, graft count estimation from photographs, and digital hairline design simulation. At Hairmedico, AI-assisted trichoscopy is part of the Algorithmic FUE planning process. Robotic extraction is not used — Dr. Arslan's manual FUE achieves lower transection rates across all hair types.
AI simulation tools can show proposed hairline positions on photographs, but cannot predict actual graft survival (depends on surgeon quality), actual density (depends on hair calibre), or how the result interacts with future native hair loss. They are design communication aids, not result guarantees.
Not in the foreseeable future. AI adds value in data analysis (density mapping, graft counting) but cannot replace the aesthetic judgment required for natural hairline design, the technical adaptation required for diverse hair types, or the long-term clinical planning that accounts for individual hair loss trajectories.
- International Society of Hair Restoration Surgery. Practice census — global hair restoration statistics.. 2022. fue-europe.com
- Onda M et al. Follicular unit extraction: a systematic review. J Plastic & Aesthetic Chirurgie. 2020. doi.org
- NHS. Hair loss — overview. National Health Service UK. 2023. nhs.uk
- MedlinePlus NIH. Hair transplantation — clinical overview. U.S. National Library of Medicine. 2024. medlineplus.gov
- Bernstein RM. Follicular unit transplantation. Dermatologic Cliniques. 2013. doi.org
All references are peer-reviewed medical literature or official health authority publications. No commercial sources included.
Dr. Arslan Musbeh
- ✓ FUE Europe — Full Member
- ✓ Ministry of Health accredited
- ✓ 17+ years · 3,000+ cases
- ✓ One patient per day
- ✓ Algorithmic FUE™ creator